Company Name:Myriad Genetics Inc.
CEO: Mark Christopher Capone

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.


Key numbers

Market Capitalization:2136452080
Shares Outstanding: 74389000
Float: 72215725
Next Earning Date:2020-02-11
TTm EPS: -0.2076
TTm Dividend Rate:
200 days moving average:28.23
50 days moving average: 26.13
One day percent Change: -0.69



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-06-30, 2016-06-30, 2017-06-30, 2018-06-30,
2015-06-30, 2016-06-30, 2017-06-30, 2018-06-30,